Delivering a new class of neuromuscular therapeutics in psychiatry
Updates & Press Releases
-
Healis Therapeutics founded to deliver new class of neuromuscular treatments in psychiatry
Healis Co-Founder and CEO Dr. Eric Finzi first made headlines in 2006 when he published the first trial showing efficacy of botulinum toxin in treating major depressive disorder (MDD). Subsequently, five Phase II clinical trials have shown…